Chemours Co (CC)
Chemours Co (CC) from its SEC filings: 2025 revenue $5.8 billion (+0% vs the year before), net margin -7%, free cash flow $51.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Chemicals & Allied Products |
| Revenue (2025) | $5.8 billion |
| Revenue growth | +0% |
| Net income | -$386.0 million |
| Net margin | -6.6% |
| Free cash flow | $51.0 million |
| Diluted EPS | $-2.57 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -2% |
| Cash | $671.0 million |
| Long-term debt | $3.8 billion |
| Share count, 1 year | +0% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.